Skip to main content

Branded

  • FDA clears Accu-Chek Combo, a blood-glucose meter and insulin pump device

    INDIANAPOLIS — Roche on Wednesday announced that it has received clearance from the Food and Drug Administration for its Accu-Chek Combo system for insulin pump therapy.

  • FDA approves weight-loss drug

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new weight-loss drug made by Vivus, the agency said.

    The FDA announced the approval of Qsymia (phentermine and topiramate) extended-release, designed for use by overweight and obese adults alongside a reduced-calorie diet and exercise for chronic weight management. The drug's original brand name was Qnexa.

  • GlaxoSmithKline to acquire Human Genome Sciences for $3.6 billion

    LONDON — British drug maker GlaxoSmithKline will acquire development partner Human Genome Sciences for $3.6 billion, GSK said Monday.

    The deal, worth $14.25 per share, would give GSK full ownership of the lupus drug Benlysta (belimumab), as well as albiglutide, an experimental drug for diabetes, and darapladib, an experimental heart disease drug.

  • UCB launches Neupro transdermal patch

    ATLANTA — UCB has launched a new drug for treating Parkinson's disease and restless legs syndrome, the company said Monday.

    The Belgian drug maker announced the launch of Neupro (rotigotine) transdermal system, which the Food and Drug Administration approved in April. The drug is a once-daily patch that provides continuous delivery of rotigotine, a dopamine agonist, over 24 hours.

  • FDA accepts opioid drug application from Zogenix

    SAN DIEGO — The Food and Drug Administration has accepted a regulatory application for an opioid painkiller made by Zogenix, the company said Monday.

    The drug maker announced the FDA's acceptance of its application for Zohydro (hydrocodone bitartrate) extended-release capsules, designed for moderate to severe chronic pain. The company expects the FDA to decide whether or not to approve the drug by March 1, 2013.

  • Gilead's Truvada approved for PrEP

    SILVER SPRING, Md. — The Food and Drug Administration has approved a drug used to treat HIV for reducing the risk of HIV infection, the agency said Monday.

  • Despite penalties, counterfeits continue

    Another prescription drug-related crime is drug counterfeiting, which got significant attention in March 2011 when CBS News’ “60 Minutes” reported on the problem, including a tour of a drug counterfeiting operation.


    In March, the Senate passed S. 1886, the Counterfeit Drug Penalty Enhancement Act, which toughens punishments for criminals who produce and traffic counterfeit medications, drawing praise from the National Association of Chain Drug Stores.


  • Sanofi Pasteur begins shipping Fluzone in U.S. for 2012-2013 season

    SWIFTWATER, Pa. — Sanofi Pasteur has begun shipping the first lots of its influenza vaccine for the 2012-2013 season.

X
This ad will auto-close in 10 seconds